Literature DB >> 19287802

Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease.

Maria Jedrzejowska1, Michał Milewski, Janusz Zimowski, Janina Borkowska, Anna Kostera-Pruszczyk, Danuta Sielska, Marta Jurek, Irena Hausmanowa-Petrusewicz.   

Abstract

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disorder caused by mutations of the SMN1 gene. It is characterized by significant phenotype variability. In this study, we analyzed possible phenotype modifiers of the disease - the size of the deletion in the SMA region, the number of SMN2 gene copies, as well as the effect of gender. Among the factors analyzed, two seem to influence the SMA phenotype: the number of SMN2 gene copies and a deletion in the NAIP gene. A higher number of SMN2 copies makes the clinical symptoms more benign, and the NAIP gene deletion is associated with a more severe phenotype. The influence of gender remains unclear. In a group of 1039 patients, 55% of whom were male, the greatest disproportion was in the SMA1 (F/M = 0.78) and SMA3b (F/M = 0.45) forms. In SMA1 a deletion in the NAIP gene was seen twice as frequently in girls compared to boys. In three patients, we observed genotypes atypical for the chronic forms of SMA: two patients with SMA3a and 3b had a deletion of the NAIP gene, and a third patient with SMA2 had one copy of the SMN2 gene.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19287802

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  16 in total

1.  Gender Effects on the Clinical Phenotype in Japanese Patients with Spinal Muscular Atrophy.

Authors:  Mawaddah Ar Rochmah; Ai Shima; Nur Imma Fatimah Harahap; Emma Tabe Eko Niba; Naoya Morisada; Shinichiro Yanagisawa; Toshio Saito; Kaori Kaneko; Kayoko Saito; Ichiro Morioka; Kazumoto Iijima; Poh San Lai; Yoshihiro Bouike; Hisahide Nishio; Masakazu Shinohara
Journal:  Kobe J Med Sci       Date:  2017-10-16

2.  Frequency of SMN1 deletion carriers in a Mestizo population of central and northeastern Mexico: A pilot study.

Authors:  Silvina Noemi Contreras-Capetillo; Hugo Leonid Gallardo Blanco; Ricardo Martin Cerda-Flores; José Lugo-Trampe; Iris Torres-Muñoz; Antonio Bravo-Oro; Carmen Esmer; Laura Ella Martínez DE Villarreal
Journal:  Exp Ther Med       Date:  2015-04-20       Impact factor: 2.447

3.  Complete sequencing of the SMN2 gene in SMA patients detects SMN gene deletion junctions and variants in SMN2 that modify the SMA phenotype.

Authors:  Corey Ruhno; Vicki L McGovern; Matthew R Avenarius; Pamela J Snyder; Thomas W Prior; Flavia C Nery; Abdurrahman Muhtaseb; Jennifer S Roggenbuck; John T Kissel; Valeria A Sansone; Jennifer J Siranosian; Alec J Johnstone; Pann H Nwe; Ren Z Zhang; Kathryn J Swoboda; Arthur H M Burghes
Journal:  Hum Genet       Date:  2019-02-20       Impact factor: 4.132

4.  Gender-Specific Amelioration of SMA Phenotype upon Disruption of a Deep Intronic Structure by an Oligonucleotide.

Authors:  Matthew D Howell; Eric W Ottesen; Natalia N Singh; Rachel L Anderson; Ravindra N Singh
Journal:  Mol Ther       Date:  2017-04-13       Impact factor: 11.454

5.  Genetic findings of Cypriot spinal muscular atrophy patients.

Authors:  L Theodorou; P Nicolaou; P Koutsou; A Georghiou; V Anastasiadou; G Tanteles; T Kyriakides; E Zamba-Papanicolaou; K Christodoulou
Journal:  Neurol Sci       Date:  2015-05-28       Impact factor: 3.307

6.  DNA Damage Response and DNA Repair in Skeletal Myocytes From a Mouse Model of Spinal Muscular Atrophy.

Authors:  Saniya Fayzullina; Lee J Martin
Journal:  J Neuropathol Exp Neurol       Date:  2016-07-24       Impact factor: 3.685

7.  Molecular characterization and copy number of SMN1, SMN2 and NAIP in Chinese patients with spinal muscular atrophy and unrelated healthy controls.

Authors:  Ping Fang; Liang Li; Jian Zeng; Wan-Jun Zhou; Wei-Qing Wu; Ze-Yan Zhong; Ti-Zhen Yan; Jian-Sheng Xie; Jing Huang; Li Lin; Ying Zhao; Xiang-Min Xu
Journal:  BMC Musculoskelet Disord       Date:  2015-02-07       Impact factor: 2.362

8.  Onasemnogene Abeparvovec for Spinal Muscular Atrophy: The Costlier Drug Ever.

Authors:  Rajiv Mahajan
Journal:  Int J Appl Basic Med Res       Date:  2019 Jul-Sep

Review 9.  In Search of a Cure: The Development of Therapeutics to Alter the Progression of Spinal Muscular Atrophy.

Authors:  Kristine S Ojala; Emily J Reedich; Christine J DiDonato; Stephen D Meriney
Journal:  Brain Sci       Date:  2021-02-05

10.  Severe impairment of male reproductive organ development in a low SMN expressing mouse model of spinal muscular atrophy.

Authors:  Eric W Ottesen; Matthew D Howell; Natalia N Singh; Joonbae Seo; Elizabeth M Whitley; Ravindra N Singh
Journal:  Sci Rep       Date:  2016-02-02       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.